Plasma p-tau217 successfully identified Alzheimer's pathology in several neurodegenerative syndromes. This included disorders not typically associated with Alzheimer's disease, like frontotemporal ...
While trying to develop a comparatively easy, inexpensive way to give physicians and their patients with bladder cancer a better idea of likely outcome and best treatment options, scientists found ...
To help build out its own portfolio of artificial-intelligence-driven pathology tests, Quest Diagnostics has enlisted the help of Paige to develop a suite of products aimed at individual clinical ...
Please provide your email address to receive an email when new articles are posted on . Adults with cognitive complaints received usual care by primary care physicians and were tested for blood-based ...
Researchers have used off-the-shelf components to create a sensor device that is not only cost-effective but can quickly detect 32 different pathogens and has sensitivities on par with the ...
ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (C2N), a world leader in developing Alzheimer’s disease-specific fluid biomarker tests, has received a new $15 million program-related investment from ...
Sixto M. Leal Jr., M.D., Ph.D., Jay M. McDonald Endowed Professor in Experimental Pathology and Division Director, Laboratory Medicine, has been appointed to the American Board of Pathology's (ABPath) ...
MedPage Today on MSN
Alzheimer's blood tests together improve accuracy, cut overdiagnosis
Plasma eMTBR-tau243 also could help identify people with high tau burden ...
Throughout the pandemic, Australians with a sniffle or other cold and flu symptoms have been encouraged to get a PCR test – a swab of their throat and the back of their nose, taken by a nurse or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results